<DOC>
	<DOCNO>NCT01638156</DOCNO>
	<brief_summary>This study evaluate importance arterial stiffness wave reflection determinant persistent leave ventricular ( LV ) hypertrophy fibrosis ( assess use cardiac magnetic resonance image [ MRI ] ) correction severe stenosis aortic valve . The hypothesis test whether stiff artery increase wave reflection impede pump blood LV aortic valve replacement ( AVR ) precent adequate regression ( improvement ) hypertrophy fibrosis myocardium despite correction aortic valve stenosis .</brief_summary>
	<brief_title>Cardiac MRI Severe Aortic Stenosis</brief_title>
	<detailed_description>A total 80 participant enrol study site protocol-required technology . The Pennsylvania Department Health fund trial limit site Pennsylvania . Participants undergo pre- post-operative cardiac MRI , blood draw , 6-minute walk test , arterial tonometry , medical history assessment , quality-of-life questionnaire characterize pathophysiologic factor cause variability regression AVR . Researchers evaluate role specific hemodynamic abnormality determinants post-AVR LV remodeling ( LV hypertrophy LV myocardial fibrosis ) see contrast-enhanced cardiac MRI . The trial also evaluate non-contrast-enhanced MRI approach ( T1rho ) potentially effective assess LV myocardial fibrosis .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>18 year age old Severe symptomatic aortic stenosis ( estimate aortic valve area &lt; 1 cm2 ) 1,2 document transthoracic echocardiogram ( ECG ) perform within 4 month prior enrollment Planned AVR within 8 week enrollment Able cardiac MRI within 3 week prior AVR surgery A preoperative coronary angiography demonstrate absence hemodynamicallysignificant CAD need revascularization AVR surgery Able tolerate cardiac MRI gadolinium contrast require protocol , perform ACRINqualified facility use ACRINqualified MR scanner Willing able provide write informed consent Not suitable undergo cardiac MRI use contrast agent gadolinium : Claustrophobia Presence metallic object implant medical device body ( i.e. , implanted cardiac pacemaker defibrillator , central nervous system aneurysm clip , implanted neural stimulators , cochlear implant , ocular foreign body [ e.g. , metal shaving ] , implant medical device [ e.g. , drug infusion port ] , insulin pump , surgical clip , prosthesis , artificial heart , valve steel part , metal fragment , shrapnel , tattoo near eye , steel implant ) Weight great allowable MRI table Known LV ejection fraction &lt; 50 % Previous aortic valve surgery Planned additional valve repair/replacement Infective endocarditis Moderate severe aortic valve regurgitation Rhythm sinus rhythm ( i.e. , atrial fibrillation ) result irregular heartbeat , compromise quality MRI tonometry data acquisition , document ECG perform within 8 week prior enrollment Presence hemodynamicallysignificant CAD would require revascularization AVR surgery Myocardial infarction unstable angina previous month Estimated glomerular filtration rate ( eGFR ) &lt; 60 mL/min/1.73m2 body surface area document within 4 week prior enrollment NOTE : This threshold deem appropriate study , rather &lt; 30 mL/min/1.73m2 , since eGFR likely decrease participant baseline 6month examination . The protocol call gadolinium administration 6month evaluation , gadolinium administration contraindicate presence eGFR &lt; 30 mL/min/1.73m2 . Therefore , initially exclude patient eGFR &lt; 60 mL/min/1.73m2 minimize presence eGFR &lt; 30 mL/min/1.73m2 time 6month evaluation . An eGFR &lt; 30 mL/min/1.73m2 body surface area acute kidney injury contraindication gadolinium contrast administration , participant insufficient kidney function immediately 6month cardiac MRI undergo MRI without contrastenhancement continue onstudy . Presence bicuspid aortic valve , associate intrinsic aortopathy may affect arterial load right ; Resting heart rate &gt; 120 beat per minute , systolic blood pressure &gt; 180 mm Hg , diastolic blood pressure &gt; 100 mm Hg Pregnancy intent become pregnant Conditions would make study measurement less accurate unreliable ( i.e. , frequent premature beat may affect cardiac gating , anatomic neck characteristic impede arterial tonometry , inability perform adequate breath hold cardiac MRI acquisition ) reliable postoperative followup patient ( least 6 month postAVR ) unlikely Known peripheral vascular disease , may limit ability exercise independently cardiac status due claudication Unwillingness patient undergo cardiac MRI Unwillingness patient sign consent form Any condition limit life expectancy &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Aortic stenosis</keyword>
</DOC>